宏源药业:年产7000吨VC添加剂项目正处于建设中

中金财经
Feb 04

  证券之星消息,宏源药业(301246)02月04日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好,请问7000吨VC啥时候投产?产能规划是7000吨还是更多?另外有没有LIFSI或者别的产品的现有产能及规划产能(包括参股公司)?VC,LIFSI等其他添加剂看起来更有上涨空间,请公司重视,未雨绸缪!另外医药现在的业务情况也请说明下现状及展望,目前医药业务是不是拖油瓶?公司股价到现在还远没有到上市发行价格,不觉得脸红么!宏源药业回复:您好,公司年产7000吨VC添加剂项目正处于建设中,预计在2026年四季度可以投产,目前还没规划LIFSI等其他添加剂。关于医药行业,公司已建立了较为完善的医药产业链,产品销往全球几十个国家和地区,与国内外知名制药企业建立了良好的合作关系。未来,公司将持续推进高端原料药、特色医药中间体和医药制剂产品的一体化发展,同时进一步拓展国际市场,并在国内市场大力推进仿制药的报批,不断丰富公司医药产品管线,提升医药板块的业务规模和市场竞争力。感谢您的关注!为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10